TRICYCLIC ANTITUMOR COMPOUNDS BEING FARNESYL PROTEIN TRANSFERASE INHIBITORS
申请人:SCHERING CORPORATION
公开号:EP1313725B1
公开(公告)日:2007-04-11
US7342016B2
申请人:——
公开号:US7342016B2
公开(公告)日:2008-03-11
Novel farnesyl protein transferase inhibitors as antitumor agents
申请人:Schering Corporation
公开号:US20040122018A1
公开(公告)日:2004-06-24
Disclosed are novel tricyclic compounds represented by the formula (1.0):
1
and a pharmaceutically acceptable salt or solvate thereof. The compounds are useful for inhibiting farnesyl protein transferase. Also disclosed are pharmaceutical compositions comprising compounds of formula 1.0. Also disclosed are methods of treating cancer using the compounds of formula 1.0.